ArticleMetabolic brain disease2025
Quercetin inhibited chronic unpredictable mild stress-induced mouse depressive behaviors through attenuating lateral Habenula neuronal activities.
Article in Metabolic brain disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a flavonoid, quercetin has shown anti-tumor, anti-inflammation, and anti-depressant effects. However, the exact anti-depressant mechanism of quercetin remains unclear. In this study, a combination of behavioral tests and neuropharmacological methods were used to investigate whether the endocannabinoid (eCB) system in the lateral habenula (LHb) mediated the anti-depressant pathogenesis of quercetin. Depressive model was prepared by chronic unpredictable mild stress (CUMS) in C57 mice. The CUMS exposure led to depressive-like behaviors and an increase of the miniature excitatory postsynaptic current (mEPSC) frequency in the LHb neurons, which were blocked by quercetin intragastrically administered for 14 days. As quercetin has been shown to upregulate the mRNA expression of cannabinoid receptor 1 (CB1) in cultured tumor cells, and the inhibitory effect of eCB system activation is related to glutamatergic neurons, depolarization-induced suppression of excitation (sDSE) was detected. The results showed that presynaptic inhibitory effect of eCB system was significantly down-regulated in the LHb of CUMS model, and the down-regulation was abolished by quercetin. Blocking eCB system in the LHb with CB1 antagonist AM251 rescued the neuroprotective effects of quercetin in CUMS mice. Taken together, the results suggested that eCB system in the LHb was involved in the anti-depressant effects of quercetin.
Indexed as
Identifiers
40085279What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.